US and China Agree to Slash Tariffs & Time to Overhaul Air Traffic Control?
Episode 580: Neal and Toby discuss the latest trade news where the US and China agreed to a tariff deal for the next 90 days while talks are still ongoing. Then, another flight fiasco in Newark Airport prompts the Federal government to propose an overhaul of air traffic control. Next, Elizabeth Holmes’ husband is reportedly raising millions for a blood-testing startup…sound familiar? Also, companies are facing increased scrutiny for ‘bait and switch’ pricing tactics. Meanwhile, trade talks with China continue to cool tensions and Olivia and Liam continue to be popular baby names. Finally, what you need to know in the week ahead.
Subscribe to Morning Brew Daily for more of the news you need to start your day. Share the show with a friend, and leave us a review on your favorite podcast app.
Visit endthecampaign.com for more
Listen to Morning Brew Daily Here: https://www.swap.fm/l/mbd-note
Watch Morning Brew Daily Here: https://www.youtube.com/@MorningBrewDailyShow
Learn more about your ad choices. Visit megaphone.fm/adchoices
- Datum:
- Duur:
Meer afleveringen van Morning Brew Daily
-
Boeing Scores $96B Deal with Qatar & ‘Max’ Gets Its ‘HBO’ Back
Episode 583: Neal and Toby recap the massive deal between Boeing and Qatar Airways during President Trump’s Gulf trip. Then, students are finding out their professors are starting to use ChatGPT for their coursework. Is it hypocrisy?... -
Airbnb Gets Into Luxury Lifestyle & ESPN's New Streaming App
Episode 582: Neal and Toby talk about the latest inflation report that shows the CPI rate slowing down despite tariff worries. Then, ESPN revealed some details about its standalone streaming service. Also, tech companies may have a spy... -
Markets Rally On US-China Deal & Big Pharma Grapples with Price Cuts?
Episode 581: Neal and Toby recap the aftermath of the US-China trade deal that essentially de-escalates the tariff volley between each superpower. Then, Trump vows to slash drug prices for Americans, which has Pharma companies worried...